Drilling Into Last Week’s Legislative Action: How the New Law Impacts Rare-Disease Development
Shares:
The idea that hospitals are marking up prices on medicines -- not by a little, but by a whole lot -- is not a new one. PhRMA has been waving
I’m usually loathe to link to articles that are behind particularly high paywalls, but I’m going to make an exception. If you subscribe to BioCentury, check out this piece on
It’s inauguration day today, and I have no great insights on what is to come from a health policy POV. So I will repeat my standard mantra/gif about what’s next: